Cite
HARVARD Citation
Mathiesen, D. et al. (2022). Long-acting amylin analogues for the management of obesity. Current opinion in endocrinology, diabetes and obesity. 29 (2), pp. 183-190. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mathiesen, D. et al. (2022). Long-acting amylin analogues for the management of obesity. Current opinion in endocrinology, diabetes and obesity. 29 (2), pp. 183-190. [Online].